Skip to content

Roles of Vitamin D and HDL in Obese Children

Roles of Vitamin D and HDL in Obese Children

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02135913
Enrollment
1
Registered
2014-05-12
Start date
2016-01-01
Completion date
2017-04-26
Last updated
2017-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low HDL, Obese, Vitamin D Deficiency

Keywords

Obese, Children, Vitamin D deficiency, Low HDL

Brief summary

This is a pilot study to determine the association between Vitamin D deficiency in obese children and low high density lipoprotein (HDL) and dysfunctional HDL.

Detailed description

Subjects will be identified through the Department of Pediatric - High Body Mass Index (BMI) Clinic by Dr. Aurelia Radulescu during standard of care visit. Dr. Radulescu will determine if the subject meets study eligibility requirements. Visit 1 (Baseline/Screening): Consent/assent will be obtained, medical history, demographic information along with height and weight will be collection. Clinical Laboratory testing, although not part of this study, will include the following standard of care tests. The results of Vitamin D and Lipid profile testing will be shared with Dr. Li by Dr. Radulescu. * Lipid profile * Vitamin D * AST/ALT * Hb A1C * Glucose * CBS w/diff * TSH * BUN, Creatine * UA Subjects will be placed on standard of care Vitamin D supplementation for 12 weeks. Visit 2 (3 month visit) End of Study: Subjects will return to the BMI clinic at month 3 for follow-up and additional clinical laboratory testing (see visit 1 for a description of testing to be performed) in order to assess their response to Vitamin D supplementation. Subjects with previously reported abnormal Lipid values will have a Lipid profile repeated at this visit. Month 3 visit will be the End of Study visit.

Interventions

DIETARY_SUPPLEMENTVitamin D

All subjects enrolled into the study will be prescribed standard of care Vitamin D

Sponsors

Xiang-An Li
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Obese children * Vitamin D deficiency * Low HDL

Exclusion criteria

* HIV * Hepatitis A * Hepatitis B * Hepatitis C * Non-English speaking

Design outcomes

Primary

MeasureTime frameDescription
Laboratory Analysis of Vitamin D blood levels before Vitamin D Supplementationup to 24 monthsVitamin D deficiency in obese child leads to low HDL and dysfunctional HDL

Secondary

MeasureTime frameDescription
Laboratory Analysis of Vitamin D Blood Levels following Vitamin D Supplementationup to 24 monthsSupplementation of Vitamin D to obese children with low Vitamin D/low HDL corrects Vitamin D deficiency, restores HDL levels and functions.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026